TURBO UNLIMITED LONG- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - STRYKER CORP. Share Price

Certificat

DE000SB074Z0

Real-time Bid/Ask 16:29:09 02/05/2024 BST
10.28 EUR / 10.32 EUR -9.73% Intraday chart for TURBO UNLIMITED LONG- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - STRYKER CORP.
1 month-11.82%
3 months+16.55%
Date Price Change Volume
02/05/24 10.21 -10.52% 0
30/04/24 11.41 -0.78% 0
29/04/24 11.5 +1.86% 0
26/04/24 11.29 -0.70% 0
25/04/24 11.37 -0.26% 0

Delayed Quote Börse Stuttgart

Last update May 02, 2024 at 03:42 pm

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying STRYKER CORPORATION
IssuerLogo Issuer Société Générale Société Générale
WKN SB074Z
ISINDE000SB074Z0
Date issued 09/06/2020
Strike 216.4 $
Maturity Unlimited
Parity 10 : 1
Emission price 3.22
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 13.44
Lowest since issue 0.36
Spread 0.04
Spread %0.39%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
328.1 USD
Average target price
371.9 USD
Spread / Average Target
+13.35%
Consensus